Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 17 Jul 2026 for Monte Rosa Therapeutics, Inc., €192k. Read the official filing
Filing timeline
BuySaleMarkus Warmuth
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Markus Warmuth: trading record in brief
Markus Warmuth is a declared insider of Monte Rosa Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 2 January 2025 to 16 July 2026, the count stands at 6 filings.
The open-market record consists of 4 sales worth €469k, with no purchase. Outside the open market, there are 2 share grants. Since January 2026: no purchases and 4 sales on the market.
Most recently, on 17 July 2026, the filings show an open-market sale worth €192k in Monte Rosa Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Markus Warmuth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
9,500 shares@ US$23.18090.022% mcap34.5% of flowCommon StockSEC:0001193125-26-307791:0
8,000 shares@ US$17.64060.011% mcap21.5% of flowCommon StockSEC:0001193125-26-156981:0
5,466 shares@ US$17.924315.0% of flowCommon StockSEC:0001193125-26-091733:0
3,707 shares@ US$23.242213.2% of flowCommon StockSEC:0001193125-26-008902:0
90,000 sharesCommon StockSEC:0001193125-26-002389:0
128,000 sharesCommon StockSEC:0000950170-25-002100:0
6 of 6 declarations
